About 500 reports

  • Global Kaposi sarcoma HAART therapy market 2016-2021 ($ millions)
  • MARKET DRIVERS

About Kaposi Sarcoma Kaposi sarcoma is a multicentral tumor. The tumor is caused by Kaposi sarcoma-associated herpesvirus (KSHV) also known as human herpesvirus 8 (HHV8). It can occur as endemic, classic, epidemic, and iatrogenic forms. Epidemic or acquired immune deficiency syndrome (AIDS)-associated form of treatment is...

  • Cancer
  • Forecast
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Cervical Cancer Diagnostics Market: Product Outlook

AIDS Acquired immune deficiency syndrome ##.

  • Cancer
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Hologic, Inc.

However, the region holds strong potential due to hundreds of clinical trials being performed in the region, more specifically in the US, for the treatment of cancer, HIV/ AIDS, and other diseases.

  • Cancer
  • World
  • Forecast
  • Market Size
  • Celgene Corporation

The company manufacturers pharmaceuticals for the treatment of cancer, diabetes, HIV/ AIDS, cardiovascular disease, etc.

  • Cancer
  • China
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.

Going forward, we plan to begin providing products and services in the urinalysis and hemostasis fields, the life science field and to address three of the most leading infectious diseases (HIV/ AIDS, tuberculosis and malaria), expanding our existing product portfolio centered

  • Cancer
  • Immunochemistry Test
  • World
  • Demand
  • Sysmex Corporation

© IGATE RESEARCH PAGE ## OF ## Global Cervical Cancer Screening Market - Overview Cervical cancer is one of the most prevalent forms of cancer affecting women all over the world.

  • Cancer
  • Cervical Cancer
  • Medical Device
  • Sexually Transmitted Disease
  • Forecast

PRIOR TO JOINING GLOBALDATA, NATASHA WORKED AS AN EPIDEMIOLOGIST FOR THREE YEARS IN THE HIV/ AIDS SURVEILLANCE PROGRAM AT THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH (MDPH).

  • Cancer
  • Hormone
  • Prostate Cancer
  • Therapy
  • PROVENGE group
  • 11.3 Factors that Impede Market Growth

Bowel wall perforation or tears Bleeding Infection and other blood-borne diseases such as hepatitis, HIV, and AIDS can be transmitted from one individual to the other if sterilization is not done properly.

  • Cancer
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • Hoya Corporation
  • Olympus Corporation

The result could be obtained back within one hour.

  • Cancer
  • Southeast Asia
  • Western Europe
  • World
  • Forecast

They' re striving toward this goal through public/ private partnerships like SECURE THE FUTURE, their pioneering $## million HIV/ AIDS program in Africa, and through their patient assistance programs.

  • Cancer
  • China
  • Demand
  • Trade
  • Sanofi-Synthelabo Inc.

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Cancer
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

HIV/ AIDS, Tuberculosis (TB) remains a global public health problem and is one of the three leading causes of deaths worldwide due to infectious diseases.

  • Cancer
  • North America
  • United States
  • bioMerieux S.A.
  • Cepheid

They' re striving toward this goal through public/ private partnerships like SECURE THE FUTURE, their pioneering $## million HIV/ AIDS program in Africa, and through their patient assistance programs.

  • Cancer
  • China
  • Demand
  • Novartis AG
  • Sanofi-Synthelabo Inc.

Disease control efforts for viral Hepatitis, Tuberculosis and HIV/ AIDS remain important issues for China.

  • Cancer
  • In Vitro Diagnostic Reagent
  • China
  • East Asia
  • OriGene Technologies, Inc.
  • TREATMENT USAGE RATES
  • TREATED POPULATION

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 Summary Cancer is anticipated to become increasingly prevalent due to aging populations and rising levels of obesity in the developed world. Cancer vaccines...

  • Cancer
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.

Cervical Cancer Mortality Population (2001 - 2011) ##.

  • Cancer
  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • Medical Device
  • Forecast

They' re striving toward this goal through public/ private partnerships like SECURE THE FUTURE, their pioneering $## million HIV/ AIDS program in Africa, and through their patient assistance programs.

  • Cancer
  • China
  • Bristol-Myers Squibb China Inc Ltd
  • Sanofi-Synthelabo Inc.
  • Schering-Plough Corporation

However, it is also one of the most preventable types of cancer.

  • Cancer
  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • North America
  • Forecast

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Cancer
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • MARKET OUTLINE

However, Africa is the major market for infectious diseases because of increased prevalence of UTIs and HIV.

  • Cancer
  • Sexually Transmitted Disease
  • Abbott Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.

These points have been further sub ##.

  • Cancer
  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • Southeast Asia
  • Forecast

They' re striving toward this goal through public/ private partnerships like SECURE THE FUTURE, their pioneering $## million HIV/ AIDS program in Africa, and through their patient assistance programs.

  • Cancer
  • China
  • Biostar Pharmaceuticals, Inc.
  • Novartis AG
  • Sanofi-Synthelabo Inc.

THESE STUDIES INTO THE SAFETY AND EFFICACY OF INVESTIGATIONAL PRODUCTS FIGURE ##-##: GSK VACCINE PRODUCT PIPELINE IMPACT AROUND THE WORLD, INCLUDING MALARIA, HIV, TB AND EBOLA.

  • Cancer
  • World
  • GlaxoSmithKline plc
  • Meningococcal group
  • Pfizer Inc.
  • 3.2 RISK FACTORS AND COMORBIDITIES
  • Risk Factors and Comorbidities for NHL

EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2024 Summary Non-Hodgkin’s Lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the body’s immune system is affected by the uncontrollable growth of malignant white blood cells, resulting in the body’s inability to fight...

  • Cancer
  • Japan
  • United States
  • World
  • Forecast

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Cancer
  • Australia
  • United States
  • World
  • Forecast

Government' s initiative to deliver life-saving services and improve the lives of those living with HIV/ AIDS around the world.

  • Cancer
  • Cell Therapy
  • HIV AIDS
  • Therapy
  • United States

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Cancer
  • China
  • Japan
  • United States
  • Forecast

" These Extensively Drug Resistant (XDR) bacteria often affect the young, the elderly, pregnant women and people who are immunocompromised such as cancer chemotherapy, HIV/ AIDS, and organ transplant patients.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Australia
  • Agilent Technologies, Inc.

OUR LEAD PROJECT IS A THERAPEUTIC VACCINE FOR HIV.

  • Cancer
  • China
  • Celgene Corporation
  • Juno Therapeutics Inc.
  • Novartis AG

HE IS EXPERIENCED IN DESIGNING AND EXECUTING OPERATIONAL RESEARCH STUDY ON HIV/ AIDS SERVICES UPTAKE AMONG HIGH RISK GROUPS (HRGS) IN INDIA.

  • Cancer
  • Sexually Transmitted Disease
  • Japan
  • United States
  • Forecast